Skip to content
Nonprofiteer
← HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE

Form 990 for tax year 2022

Filed by HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE.

Totals

Total revenue
$4,975,112
Total expenses
$4,925,372
Contributions and grants received
$4,887,207
Grants paid
$434,237
Program service revenue
$10,643
Investment income
$77,262
Other revenue
$0
Total assets, end of year
$9,947,407
Total liabilities, end of year
$3,610,004
Net assets or fund balances, end of year
$6,337,403
Program services expenses (Part IX)
$4,228,096
Management and general expenses
$684,639
Fundraising expenses
$12,637
Program service expenses (Part III)
$4,228,096

Program services were 85.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1b · Membership dues

    $1,395,128

  • 1e · Government grants (contributions)

    $1,053,220

  • 1f · All other contributions, gifts and grants

    $2,438,859

  • 2a · Program service revenue: REGISTRATIONS

    total $10,643 · related or exempt $10,643

  • 3 · Investment income

    total $134,419 · excluded $134,419

  • 7a · Gross sales of assets other than inventory

    securities $1,265,075

  • 7b · Less cost or other basis and sales expenses

    securities $1,322,232

  • 7c · Gain or loss

    securities -$57,157

  • 7d · Net gain or loss

    total -$57,157 · excluded -$57,157

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $373,776 · program services $373,776

  • 2 · Grants to domestic individuals

    total $2,000 · program services $2,000

  • 3 · Grants to foreign organizations and individuals

    total $58,461 · program services $58,461

  • 5 · Compensation of officers, directors and key employees

    total $353,970 · program services $290,263 · management and general $58,995 · fundraising $4,712

  • 7 · Other salaries and wages

    total $1,338,200 · program services $1,227,582 · management and general $109,247 · fundraising $1,371

  • 8 · Pension plan contributions

    total $109,579 · program services $98,290 · management and general $10,895 · fundraising $394

  • 9 · Other employee benefits

    total $85,064 · program services $76,301 · management and general $8,457 · fundraising $306

  • 10 · Payroll taxes

    total $124,332 · program services $111,523 · management and general $12,362 · fundraising $447

  • 11c · Fees: accounting

    total $16,682 · management and general $16,682

  • 11f · Fees: investment management

    total $12,458 · management and general $12,458

  • 11g · Fees: other

    total $83,798 · program services $80,396 · management and general $3,402

  • 13 · Office expenses

    total $68,201 · program services $32,628 · management and general $31,973 · fundraising $3,600

  • 14 · Information technology

    total $97,954 · program services $93,630 · management and general $4,324

  • 16 · Occupancy

    total $324,338 · program services $290,925 · management and general $32,247 · fundraising $1,166

  • 17 · Travel

    total $162,042 · program services $134,766 · management and general $27,276

  • 19 · Conferences, conventions and meetings

    total $71,425 · program services $62,956 · management and general $8,469

  • 22 · Depreciation, depletion and amortization

    total $12,667 · program services $12,667

  • 23 · Insurance

    total $17,750 · management and general $17,750

  • 24a · Other expenses: RESEARCH SUPPORT

    total $1,030,543 · program services $1,030,543

  • 24b · Other expenses: SHARED SERVICES

    total $490,638 · program services $159,895 · management and general $330,102 · fundraising $641

  • 24c · Other expenses: PUBLICATIONS

    total $91,494 · program services $91,494

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $749,496 · end of year $739,923

  • 2 · Savings and temporary cash investments

    beginning of year $45,135 · end of year $18,536

  • 3 · Pledges and grants receivable

    beginning of year $288,305 · end of year $163,109

  • 4 · Accounts receivable

    beginning of year $24,500 · end of year $31,639

  • 9 · Prepaid expenses and deferred charges

    beginning of year $0 · end of year $51,313

  • 10a · Land, buildings and equipment: cost or other basis

    $96,507

  • 10b · Land, buildings and equipment: accumulated depreciation

    $90,174

  • 10c · Land, buildings and equipment, net

    beginning of year $19,000 · end of year $6,333

  • 11 · Investments: publicly traded securities

    beginning of year $7,141,940 · end of year $6,789,320

  • 15 · Other assets

    beginning of year $108,014 · end of year $2,147,234

  • 17 · Accounts payable and accrued expenses

    beginning of year $472,942 · end of year $440,813

  • 19 · Deferred revenue

    beginning of year $588,806 · end of year $783,902

  • 25 · Other liabilities

    beginning of year $332,958 · end of year $2,385,289

  • 27 · Net assets without donor restrictions

    beginning of year $6,933,931 · end of year $6,329,650

  • 28 · Net assets with donor restrictions

    beginning of year $47,753 · end of year $7,753

Mission and programs · 2022

Mission

THE HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE (HESI) IS A NONPROFIT INSTITUTION WHOSE MISSION IS TO ENGAGE SCIENTISTS FROM ACADEMIA, GOVERNMENT, INDUSTRY, NONPROFIT, AND OTHER RESEARCH INSTITUTIONS TO IDENTIFY AND RESOLVE GLOBAL HEALTH AND ENVIRONMENTAL ISSUES.

  • CARDIAC SAFETY TECHNICAL COMMITTEE: THE MISSION OF THE CARDIAC SAFETY TECHNICAL COMMITTEE IS TO IMPROVE PUBLIC HEALTH BY REDUCING UNANTICIPATED CARDIOVASCULAR-RELATED ADVERSE EFFECTS FROM DRUGS OR CHEMICALS AND DEVELOP INNOVATIVE APPROACHES TO SUPPORT EARLY DETECTION AND PREDICTION AS WELL AS IMPROVED UNDERSTANDING OF CARDIOVASCULAR TOXICOLOGY AND PATHOBIOLOGY. IN 2022, THE COMMITTEE CONTINUED TO SPONSOR PROJECTS ADDRESSING CARDIOVASCULAR SAFETY TESTING, PUBLISHED ONE SCIENTIFIC MANUSCRIPT IN A PEER-REVIEWED TECHNICAL JOURNAL BASED ON THE COMMITTEE'S RESEARCH AND PRESENTED 8 TIMES AT PUBLIC SCIENTIFIC MEETINGS. AN ADDITIONAL 5 MANUSCRIPTS ARE IN PROGRESS. KEY PROJECTS INCLUDED INITIATION OF A NEW STUDY TO EXPLORE DRUG-INDUCED BLOOD PRESSURE CHANGES, A STUDY TO IDENTIFY BIOMARKERS OF BLEEDING DISORDERS, PROJECT PLANNING TO EXPLORE CARDIAC FUNCTION AND SODIUM CHANNEL BLOCK, AND COMPLETION OF DATA COLLECTION FOR A NEW STUDY TO EXPLORE USE OF CARDIAC STEM CELLS TO PREDICT TOXICITY. THE COMMITTEE ALSO CONTINUED THEIR SUPPORT OF TWO GRANTS AWARDED THROUGH FDA AND NIH IN SUPPORT OF A STRATEGIC FRAMEWORK TO ENHANCE THE USE OF MECHANISTIC STUDIES TO PREDICT POTENTIAL CARDIAC RISKS FOR PHARMACEUTICALS. THE GRANTS INCLUDE SUBCONTRACTS AT SEVERAL LABORATORIES IN THE US AND EUROPE.

    Expenses $797,910 · Grants $198,500 · Revenue $1,793

  • BOTANICAL SAFETY CONSORTIUM (BSC): THE BSC WAS OFFICIALLY CONVENED IN NOVEMBER 2019, AS THE RESULT OF A MEMORANDUM OF UNDERSTANDING BETWEEN THE US FDA, THE NATIONAL INSTITUTES OF HEALTH'S NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES (NIEHS), AND THE NON-PROFIT HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE (HESI). THE CONSORTIUM IS SUPPORTED VIA US FEDERAL FUNDING AND PRIVATE SECTOR CONTRIBUTIONS TO CREATE A PARTNERSHIP TO ADVANCE THE SCIENCE OF BOTANICAL EVALUATION. WITH THE ENGAGEMENT OF A BROAD GROUP OF GLOBAL STAKEHOLDERS, THE BSC'S MISSION IS TO ESTABLISH SUITABLE LEVELS OF CHEMICAL CHARACTERIZATION FOR BOTANICALS AND IDENTIFY FIT-FOR-PURPOSE IN VITRO AND IN SILICO ASSAYS THAT CAN BE USED TO EVALUATE BOTANICAL SAFETY. THE BSC IS COMPRISED OF EXPERTS IN AREAS RELATED TO PHARMACOGNOSY, NATURAL PRODUCTS CHEMISTRY, MODELING, TOXICOLOGY, AND/OR NEW APPROACH METHODOLOGIES. AN UP-TO-DATE LIST OF PARTICIPATING ORGANIZATIONS CAN BE FOUND AT WWW.BOTANICALSAFETYCONSORTIUM.ORG. PRIORITIZED TOXICITY ENDPOINTS LED TO THE FORMATION OF SIX ENDPOINT WORKING GROUPS: HEPATOTOXICITY, CARDIOTOXICITY, NEUROTOXICITY, GENOTOXICITY, DEVELOPMENTAL AND REPRODUCTIVE TOXICITY (DART), AND SYSTEMIC TOXICITY. THERE IS ALSO CONSIDERABLE FOCUS ON EVALUATION OF ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION (ADME) AND BOTANICAL-DRUG INTERACTIONS (BDIS) WITHIN THESE WORKING GROUPS. ALL TOXICOLOGICAL ENDPOINT GROUPS WORK IN COLLABORATION WITH THE CHEMICAL AND DATA ANALYSIS GROUPS FOR SUBSTANCE CHARACTERIZATION, EXPERIMENTAL DESIGN, AND ULTIMATELY, EVALUATION OF RESULTS. IN VITRO TO IN VIVO EXTRAPOLATION (IVIVE) IS A KEY CONSIDERATION FOR THE VARIOUS ENDPOINTS AND ASSAYS TO ENSURE THAT THE RESULTS FROM THE ASSAYS CAN BE APPROPRIATELY COMPARED TO AVAILABLE ANIMAL AND HUMAN SAFETY INFORMATION. IN 2022, THE BSC PRESENTED AT VARIOUS SCIENTIFIC MEETINGS INCLUDING THE SOCIETY OF TOXICOLOGY ANNUAL MEETING AND THE INTERNATIONAL CONGRESS OF TOXICOLOGY.

    Expenses $390,530 · Grants $3,723

  • EMERGING SYSTEMS TOXICOLOGY FOR THE ASSESSMENT OF RISK (ESTAR): THE MISSION OF THIS COMMITTEE IS TO DEVELOP AND DELIVER INNOVATIVE SYSTEMS TOXICOLOGY APPROACHES FOR RISK ASSESSMENT. THIS INCLUDES THE CATALYZE ADOPTION OF NEW TRANSLATIONAL AND PREDICTIVE TOOLS THAT GUIDE DECISION-MAKING BASED ON MECHANISTIC UNDERSTANDING OF TOXICOLOGICAL RESPONSE, ENGAGING THE GLOBAL SCIENTIFIC COMMUNITY TO PROMOTE INTERNATIONAL ACCEPTANCE OF GENOMIC BIOMARKERS FOR DECISION-MAKING, AND IDENTIFYING AND CHARACTERIZING BIOFLUID AND TISSUE-BASED GENOMIC BIOMARKERS FOR TOXICOLOGY. THE COMMITTEE HAS SIX ACTIVE PROJECTS, INCLUDING THE RECENTLY FORMED OMICS FOR ASSESSING SIGNATURES FOR INTEGRATED SAFETY (OASIS) CONSORTIUM, WHICH IS INVESTIGATING THE USE OF CELL PAINTING AND TRANSCRIPTOMICS FROM IN VITRO MODELS AND COMPARING THEM TO EXISTING RAT IN VIVO DATA. ANOTHER RECENTLY INITIATED PROJECT IS EVALUATING THE USE OF ERROR CORRECTED SEQUENCING TO DETECT CLONAL EXPANSION INDUCED BY NON-GENOTOXIC CARCINOGENS. EXISTING PROJECTS HAVE MADE GREAT PROGRESS AS WELL IN 2023. THE TGX-DDI PROJECT WAS AWARDED A U01 GRANT FROM THE US FDA'S BIOMARKER QUALIFICATION PROGRAM TO PERFORM A MULTI-SITE TRIAL FOR QUALIFICATION. THE COMMITTEE HAS TWO MANUSCRIPTS CLOSE TO SUBMISSION AND WILL PRESENT AT TWO SCIENTIFIC MEETINGS IN 2023.

    Expenses $390,393 · Grants $125,238

  • IN VITRO GENOTOXICITY; IMMUNOTOXICOLOGY; CT TRACS; PROTEIN ALLERGENICITY; THRIVE; DEV AND REPRODUCTIVE TOX; ECO RISK; ACSA; EMERGING ISSUES CMTE; EI OTOTOX RA; ANNUAL MEETING; PB/PK; PROTAC; COMMUNICATIONS AND OUTREACH; RA 21ST CENTURY; UVCB; GRATC; ENV EPI RA; INNOVATION PRIZE; NEOUROTOX BIOMARKERS; EXTERNAL ADVISORY; FAST FUND; BIOACCUMULATION; ANIMAL ALTERNATIVES IN ERA; PROG STRATEGY AND STEWARDSHIP; HESI HELPS, AND OTHERS.

    Expenses $2,649,263 · Grants $106,776 · Revenue $8,850

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Dr Syril Pettit

    EXECUTIVE DIRECTOR

    Total calculated
    $353,970
    From this org
    $299,879
    From related orgs
    $0
    Other
    $54,091
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $293,652
    Bonus
    $0
    Other
    $6,227
    Deferred
    $21,350
    Nontaxable benefits
    $32,741
    Filer's total
    $353,970
  • Ms Beth-Ellen Berry

    CHIEF FINANCIAL OFFICER

    Total calculated
    $224,734
    From this org
    $209,155
    From related orgs
    $0
    Other
    $15,579
    Hours/week
    10

    Schedule J breakdown matched by us

    Base
    $203,353
    Bonus
    $0
    Other
    $5,802
    Deferred
    $14,235
    Nontaxable benefits
    $1,344
    Filer's total
    $224,734
  • Dr Michelle Embry

    ASSOCIATE DIRECTOR

    Total calculated
    $200,725
    From this org
    $179,571
    From related orgs
    $0
    Other
    $21,154
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $179,121
    Bonus
    $0
    Other
    $450
    Deferred
    $12,699
    Nontaxable benefits
    $8,455
    Filer's total
    $200,725
  • Dr Connie Jiang

    SR. SCIENTIFIC PROGRAM MGR

    Total calculated
    $155,136
    From this org
    $129,700
    From related orgs
    $0
    Other
    $25,436
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $129,400
    Bonus
    $0
    Other
    $300
    Deferred
    $9,421
    Nontaxable benefits
    $16,015
    Filer's total
    $155,136
  • Dr Sandrine Deglin

    SCIENTIFIC PROGRAM MGR

    Total calculated
    $146,826
    From this org
    $128,345
    From related orgs
    $0
    Other
    $18,481
    Hours/week
    37.5
  • Ms Jennifer Pierson

    SR. SCIENTIFIC PROGRAM MGR

    Total calculated
    $140,649
    From this org
    $128,522
    From related orgs
    $0
    Other
    $12,127
    Hours/week
    37.5
  • Dr Lucilia Pereira Mouries

    SR. SCIENTIFIC PROGRAM MGR

    Total calculated
    $131,251
    From this org
    $121,530
    From related orgs
    $0
    Other
    $9,721
    Hours/week
    37.5
  • Prof Ruth A Roberts

    CHAIR

    Total calculated
    $0
    Hours/week
    2
  • Dr Martin Van Den Berg

    PAST CHAIR

    Total calculated
    $0
    Hours/week
    2
  • Dr Anthony Holmes

    PRESIDENT

    Total calculated
    $0
    Hours/week
    2
  • Dr Jon C Cook

    PAST PRESIDENT

    Total calculated
    $0
    Hours/week
    2
  • Dr David L Eaton

    TREASURER

    Total calculated
    $0
    Hours/week
    2
  • Dr Pamela J Spencer

    SECRETARY

    Total calculated
    $0
    Hours/week
    2
  • Dr Greg Adamson

    TRUSTEE (TO JUN '22)

    Total calculated
    $0
    Hours/week
    2
  • Dr Karissa Adkins

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Warren M Casey

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Roger Chammas

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Myrtle Davis

    TRUSTEE (FROM JUN '22)

    Total calculated
    $0
    Hours/week
    2
  • Dr Patricia Escobar

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Patrick D Guiney

    TRUSTEE (TO JUN '22)

    Total calculated
    $0
    Hours/week
    2
  • Dr Nina Hallmark

    TRUSTEE (FROM JUN '22)

    Total calculated
    $0
    Hours/week
    2
  • Dr Sarah A Hughes

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Jerry S H Lee

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Adam Lillicrap

    TRUSTEE (FROM JUN '22)

    Total calculated
    $0
    Hours/week
    2
  • Dr Jose E Manautou

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Charlene A McQueen

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Gary Minsavage

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Graeme Moffat

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Eliana Rosa Munarriz

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Rose Omari

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Marc Pallardy

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Tracey L Papenfuss

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr William Pennie

    TRUSTEE (TO JUN '22)

    Total calculated
    $0
    Hours/week
    2
  • Dr Stefan Pfuhler

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Hans Sanderson

    TRUSTEE (FROM JUN '22)

    Total calculated
    $0
    Hours/week
    2
  • Dr Yuko Sekino

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Kathleen Shelton

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Jean-Pierre Valentin

    TRUSTEE (FROM JUN '22)

    Total calculated
    $0
    Hours/week
    2
  • Dr Watze De Wolf

    TRUSTEE (TO JUN '22)

    Total calculated
    $0
    Hours/week
    2
  • Dr Douglas C Wolf

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Dr Carole Yauk

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Form 990 of other organizations
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

FORM 990, PART VII, SECTION A, LINE 5:
BETH-ELLEN BERRY, HESI'S CFO, WAS COMPENSATED A TOTAL OF $224,734 BY NPO SERVICES. NPO SERVICES PROVIDES ACCOUNTING, LEGAL, HR, IT AND GENERAL BUSINESS SERVICES THROUGH A SHARED SERVICES ARRANGEMENT TO A GROUP OF NONPROFIT SCIENTIFIC ORGANIZATIONS CO-LOCATED IN WASHINGTON DC OFFICE SPACE.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
0
Employees, agents and contractors (line 3c)
0
Expenditures and investments (line 3c)
$342,000

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Region Offices Employees Activity Specific services Expenditures
EUROPE 0 0 GRANTMAKING; PROGRAM ACTIVITIES SCIENTIFIC RESEARCH $200,000
EAST ASIA 0 0 PROGRAM ACTIVITIES SCIENTIFIC RESEARCH $90,000
SOUTH AMERICA 0 0 GRANTMAKING; PROGRAM ACTIVITIES SCIENTIFIC RESEARCH $21,000
MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM ACTIVITIES SCIENTIFIC RESEARCH $17,000
SUB-SAHARAN AFRICA 0 0 PROGRAM ACTIVITIES SCIENTIFIC RESEARCH $9,000
NORTH AMERICA 0 0 GRANTMAKING; PROGRAM ACTIVITIES SCIENTIFIC RESEARCH $5,000

Grants to organizations, by region (Part II)

The purpose of each grant is not shown.

Region Cash grants Manner of disbursement Noncash assistance Noncash description Valuation
EUROPE $20,000 WIRE $0 — —
EUROPE $13,690 WIRE $0 — —
EUROPE $10,000 WIRE $0 — —
Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
3
Other grantees (Part II line 3)
0
Transferred property to a foreign corporation during the year (line 1)
No
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
No
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
No

Provenance

Return type
form_990
Tax year
2022
Filed
19 October 2023
IRS schema version
2022v5.0
Source object
202322939349300842

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.